Cite
Wu HC, Rérolle D, Berthier C, et al. Actinomycin D Targets NPM1c-Primed Mitochondria to Restore PML-Driven Senescence in AML Therapy. Cancer Discov. 2021;doi: 10.1158/2159-8290.CD-21-0177.
Wu, H. C., Rérolle, D., Berthier, C., Hleihel, R., Sakamoto, T., Quentin, S., Benhenda, S., Morganti, C., Wu, C., Conte, L., Rimsky, S., Sebert, M., Clappier, E., Souquere, S., Gachet, S., Soulier, J., Durand, S., Trowbridge, J. J., Bénit, P., Rustin, P., Hajj, H. E., Raffoux, E., Ades, L., Itzykson, R., Dombret, H., Fenaux, P., Espeli, O., Kroemer, G., Brunetti, L., Mak, T. W., Lallemand-Breitenbach, V., Bazarbachi, A., Falini, B., Ito, K., Martelli, M. P., & de Thé, H. (2021). Actinomycin D Targets NPM1c-Primed Mitochondria to Restore PML-Driven Senescence in AML Therapy. Cancer discovery, . https://doi.org/10.1158/2159-8290.CD-21-0177
Wu, Hsin-Chieh, et al. "Actinomycin D Targets NPM1c-Primed Mitochondria to Restore PML-Driven Senescence in AML Therapy." Cancer discovery vol. (2021). doi: https://doi.org/10.1158/2159-8290.CD-21-0177
Wu HC, Rérolle D, Berthier C, Hleihel R, Sakamoto T, Quentin S, Benhenda S, Morganti C, Wu C, Conte L, Rimsky S, Sebert M, Clappier E, Souquere S, Gachet S, Soulier J, Durand S, Trowbridge JJ, Bénit P, Rustin P, Hajj HE, Raffoux E, Ades L, Itzykson R, Dombret H, Fenaux P, Espeli O, Kroemer G, Brunetti L, Mak TW, Lallemand-Breitenbach V, Bazarbachi A, Falini B, Ito K, Martelli MP, de Thé H. Actinomycin D Targets NPM1c-Primed Mitochondria to Restore PML-Driven Senescence in AML Therapy. Cancer Discov. 2021 Jul 23; doi: 10.1158/2159-8290.CD-21-0177. Epub 2021 Jul 23. PMID: 34301789.
Copy
Download .nbib
